Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.8 EUR | -0.77% | +0.33% | +16.41% |
23/05 | MERCK KGAA : Receives a Buy rating from UBS | ZD |
23/05 | Merck KGaA: acquisition of U.S.-based Mirus Bio | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.41% | 79.16B | |
+7.78% | 8.72B | |
-16.83% | 4.79B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Transcript : MERCK Kommanditgesellschaft auf Aktien, Q3 2021 Earnings Call, Nov 11, 2021